Wilson JM - Search Results

1

Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A.

Greig JA, Smith MK, Nordin JML, Goode T, Chroscinski EA, Buza EL, Schmidt N, Kattenhorn LM, Wadsworth S, Wilson JM. Greig JA, et al. Among authors: wilson jm. Hum Gene Ther. 2022 Apr;33(7-8):421-431. doi: 10.1089/hum.2021.108. Epub 2021 Dec 8. Hum Gene Ther. 2022. PMID: 34652966 Free PMC article.

2

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

Engelhardt JF, Simon RH, Yang Y, Zepeda M, Weber-Pendleton S, Doranz B, Grossman M, Wilson JM. Engelhardt JF, et al. Among authors: wilson jm. Hum Gene Ther. 1993 Dec;4(6):759-69. doi: 10.1089/hum.1993.4.6-759. Hum Gene Ther. 1993. PMID: 7514445 Free article.

3

Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.

Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM. Goldman MJ, et al. Among authors: wilson jm. Hum Gene Ther. 1995 Jul;6(7):839-51. doi: 10.1089/hum.1995.6.7-839. Hum Gene Ther. 1995. PMID: 7578403

4

A recombinant adenoviral vector expressing a soluble form of VCAM-1 inhibits VCAM-1/VLA-4 adhesion in transduced synoviocytes.

Chen SJ, Wilson JM, Vallance DK, Hartman JW, Davidson BL, Roessler BJ. Chen SJ, et al. Among authors: wilson jm. Gene Ther. 1995 Sep;2(7):469-80. Gene Ther. 1995. PMID: 7584125

5

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

Engelhardt JF, Litzky L, Wilson JM. Engelhardt JF, et al. Among authors: wilson jm. Hum Gene Ther. 1994 Oct;5(10):1217-29. doi: 10.1089/hum.1994.5.10-1217. Hum Gene Ther. 1994. PMID: 7849095

6

Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits.

Kozarsky KF, Bonen DK, Giannoni F, Funahashi T, Wilson JM, Davidson NO. Kozarsky KF, et al. Among authors: wilson jm. Hum Gene Ther. 1996 May 20;7(8):943-57. doi: 10.1089/hum.1996.7.8-943. Hum Gene Ther. 1996. PMID: 8727508

7

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K, Mollman J, Phillips PC, Wheeldon EB, Wilson JM. Eck SL, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Aug 1;7(12):1465-82. doi: 10.1089/hum.1996.7.12-1465. Hum Gene Ther. 1996. PMID: 8844206 Clinical Trial.

8

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

Jooss K, Yang Y, Wilson JM. Jooss K, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Aug 20;7(13):1555-66. doi: 10.1089/hum.1996.7.13-1555. Hum Gene Ther. 1996. PMID: 8864756

9

Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis.

Goldman M, Su Q, Wilson JM. Goldman M, et al. Among authors: wilson jm. Gene Ther. 1996 Sep;3(9):811-8. Gene Ther. 1996. PMID: 8875230

10

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.

Haecker SE, Stedman HH, Balice-Gordon RJ, Smith DB, Greelish JP, Mitchell MA, Wells A, Sweeney HL, Wilson JM. Haecker SE, et al. Among authors: wilson jm. Hum Gene Ther. 1996 Oct 1;7(15):1907-14. doi: 10.1089/hum.1996.7.15-1907. Hum Gene Ther. 1996. PMID: 8894682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,861 results

Search Page

Filters